Giulia Bianchi
About
Giulia Bianchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research.
According to data from OpenAlex, Giulia Bianchi has authored 127 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 53 papers in Pulmonary and Respiratory Medicine and 50 papers in Cancer Research. Recurrent topics in Giulia Bianchi's work include HER2/EGFR in Cancer Research (39 papers), Breast Cancer Treatment Studies (32 papers) and Advanced Breast Cancer Therapies (30 papers). Giulia Bianchi is often cited by papers focused on HER2/EGFR in Cancer Research (39 papers), Breast Cancer Treatment Studies (32 papers) and Advanced Breast Cancer Therapies (30 papers). Giulia Bianchi collaborates with scholars based in Italy, Spain and United States. Giulia Bianchi's co-authors include Luca Gianni, Graham Ross, Semiglazov Vf, Aňa Lluch, Pinuccia Valagussa, Tadeusz Pieńkowski, Ling‐Ming Tseng, Young‐Hyuck Im, Juan de la Haba-Rodríguez and Brigitte Poirier and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
In The Last Decade
Giulia Bianchi
120 papers receiving 6.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Giulia Bianchi Italy | 32 | 4.8k | 2.2k | 1.8k | 1.6k | 1.0k | 127 | 6.1k | ||
| Filippo Montemurro Italy | 36 | 2.8k 0.6× | 1.1k 0.5× | 1.5k 0.8× | 1.2k 0.7× | 969 0.9× | 180 | 4.4k | ||
| Arlene Chan Australia | 30 | 5.4k 1.1× | 1.7k 0.8× | 1.1k 0.6× | 2.3k 1.5× | 1.8k 1.7× | 144 | 6.8k | ||
| Irene Kuter United States | 24 | 3.4k 0.7× | 1.1k 0.5× | 1.3k 0.7× | 1.5k 0.9× | 513 0.5× | 45 | 5.3k | ||
| Priya Rastogi United States | 34 | 4.8k 1.0× | 3.5k 1.6× | 1.2k 0.7× | 1.4k 0.9× | 1.1k 1.1× | 142 | 6.7k | ||
| Marc Espié France | 46 | 3.0k 0.6× | 2.4k 1.1× | 1.9k 1.1× | 942 0.6× | 983 1.0× | 180 | 5.8k | ||
| Gilles Romieu France | 37 | 4.8k 1.0× | 1.9k 0.9× | 873 0.5× | 2.1k 1.4× | 1.2k 1.2× | 136 | 6.2k | ||
| Elżbieta Starosławska Poland | 18 | 3.1k 0.7× | 2.5k 1.1× | 943 0.5× | 2.8k 1.8× | 2.4k 2.4× | 79 | 6.1k | ||
| Juan de la Haba-Rodríguez Spain | 23 | 3.1k 0.6× | 1.8k 0.8× | 970 0.5× | 1.0k 0.7× | 576 0.6× | 127 | 4.0k | ||
| Edith A. Perez United States | 34 | 3.3k 0.7× | 1.1k 0.5× | 1.5k 0.8× | 804 0.5× | 1.2k 1.2× | 87 | 4.6k | ||
| Erika Hamilton United States | 42 | 6.0k 1.3× | 1.3k 0.6× | 1.5k 0.8× | 2.8k 1.8× | 1.9k 1.9× | 432 | 8.1k |
Countries citing papers authored by Giulia Bianchi
Since
Specialization
Citations
This map shows the geographic impact of Giulia Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Bianchi more than expected).
Fields of papers citing papers by Giulia Bianchi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Giulia Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Bianchi. The network helps show where Giulia Bianchi may publish in the future.
Co-authorship network of co-authors of Giulia Bianchi
This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Bianchi. A scholar is included among the top collaborators of Giulia Bianchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Bianchi. Giulia Bianchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Martelli, Gabriele, Francesco Barretta, Chiara Listorti, et al.. (2025). Sentinel Node Biopsy Alone Versus Sentinel Node Biopsy Plus Axillary Dissection in cT2 cN0/1 Breast Cancer After Neoadjuvant Chemotherapy: 15-Year Results of a Prospective Interventional Study. Annals of Surgical Oncology. 33(3). 2255–2266.
2.
Conté, Pierfranco, Maria Vittoria Dieci, Giancarlo Bisagni, et al.. (2024). A-BRAVE trial: A phase III randomized trial with avelumab in early triple-negative breast cancer with residual disease after neoadjuvant chemotherapy or at high risk after primary surgery and adjuvant chemotherapy.. Journal of Clinical Oncology. 42(17_suppl). LBA500–LBA500.
3.
Iandelli, Andrea, Francesco Mazzola, Giulia Bianchi, et al.. (2024). Donor site scar preference in head and neck free flap reconstruction: The patient point of view. SHILAP Revista de lepidopterología. 10. 100453–100453.
4.
Agresti, Roberto, Marco Sandri, Giuseppe Capri, et al.. (2024). Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial. British journal of surgery. 112(3).
5.
Vernieri, Claudio, Francesca Ligorio, Claudia De Angelis, et al.. (2023). 352TiP Neoadjuvant chemo-immunotherapy plus/minus fasting-like approach in stage II-III triple-negative breast cancer patients: The phase II randomized BREAKFAST-2 trial. Annals of Oncology. 34. S322–S323.
6.
Neven, Patrick, PA Fasching, Stephen Chia, et al.. (2023). Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant. Breast Cancer Research. 25(1). 103–103.
7.
Alfieri, Sara, Cinzia Brunelli, Claudia Borreani, et al.. (2023). Characterizing Different Multidisciplinary Team Models Implemented Within One Comprehensive Cancer Center. Journal of Multidisciplinary Healthcare. Volume 16. 1845–1855.
8.
Aftimos, Philippe, Nicholas C. Turner, Joyce O’Shaughnessy, et al.. (2023). 386MO Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial. Annals of Oncology. 34. S340–S341.
9.
Zocchi, Jacopo, Giulia Bianchi, Oreste Iocca, et al.. (2022). Occult Neck Metastases in Head and Neck Adenoid Cystic Carcinoma: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 11(16). 4924–4924.
10.
Cammaroto, Giovanni, Giulia Bianchi, Giuseppe Meccariello, et al.. (2020). Acquired Nasopharyngeal Stenosis Correction Using a Modified Palatal Flaps Technique in Obstructive Sleep Apnea (OSA) Patients. International Journal of Environmental Research and Public Health. 17(6). 2048–2048.
11.
Fasching, Peter A., J. Thaddeus Beck, Arlene Chan, et al.. (2020). Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study. The Breast. 54. 148–154.
12.
Zattarin, Emma, Chiara Fabbroni, Francesca Ligorio, et al.. (2020). 300P Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study. Annals of Oncology. 31. S362–S363.
13.
Ligorio, Francesca, Lorenzo Castagnoli, Emma Zattarin, et al.. (2020). 175P Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)–positive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy. Annals of Oncology. 31. S312–S312.
14.
Cosimo, Serena Di, Valentina Appierto, Marco Silvestri, et al.. (2019). Circulating tumor DNA and disease recurrence in early stage breast cancer: From a case-control study to a prospective longitudinal trial. Annals of Oncology. 30. iii28–iii29.
15.
Mariani, Gabriella, Giulia Galli, Stefano Cavalieri, et al.. (2017). Long term results of ASTER study, a single Institution phase II trial of sequential chemotherapy (CT) for operable breast cancer (BC). Annals of Oncology. 28. vi34–vi34.
16.
Martelli, Gabriele, Rosalba Miceli, Secondo Folli, et al.. (2017). Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study. European Journal of Surgical Oncology. 43(11). 2012–2020.
17.
Agresti, Roberto, Marco Sandri, Massimiliano Gennaro, et al.. (2016). Evaluation of Local Oncologic Safety in Nipple–Areola Complex-sparing Mastectomy After Primary Chemotherapy: A Propensity Score-matched Study. Clinical Breast Cancer. 17(3). 219–231.
18.
Bianchi, Giulia, et al.. (2014). Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options available.. PubMed. 99(6). 269e–72e.
19.
Hurvitz, Sara A., Luc Dirix, Judit Kocsis, et al.. (2013). Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer. Journal of Clinical Oncology. 31(9). 1157–1163.
20.
Bianchi, Giulia, W. Eiermann, Giordano Vitali, et al.. (2003). Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer.. PubMed. 9(16 Pt 1). 5944–51.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Filippo Montemurro Breakdown of academic impact, for papers by Arlene Chan Breakdown of academic impact, for papers by Irene Kuter Breakdown of academic impact, for papers by Priya Rastogi Breakdown of academic impact, for papers by Marc Espié Breakdown of academic impact, for papers by Gilles Romieu Breakdown of academic impact, for papers by Elżbieta Starosławska Breakdown of academic impact, for papers by Juan de la Haba-Rodríguez Breakdown of academic impact, for papers by Edith A. Perez Breakdown of academic impact, for papers by Erika Hamilton